STERIS plc Comprehensive Income
STERIS plc (STE) reported Comprehensive Income of $186.00 million for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-07.
Financial Statements › Income Statement › Unrealized Gains
us-gaap:ComprehensiveIncomeNetOfTax · last filed 2026-08-07
- STERIS plc comprehensive income (loss), net of tax, attributable to parent for the quarter ending 2026-06-30 was $186.00M, a 53.41% decline year-over-year.
- STERIS plc comprehensive income (loss), net of tax, attributable to parent for the quarter ending 2026-03-31 was $149.80M, a 34.18% decline year-over-year.
- STERIS plc comprehensive income (loss), net of tax, attributable to parent for the quarter ending 2025-12-31 was $226.20M.
- STERIS plc comprehensive income (loss), net of tax, attributable to parent for the quarter ending 2025-09-30 was $186.30M, a 39.38% decline year-over-year.
- STERIS plc comprehensive income (loss), net of tax, attributable to parent for fiscal 2026 was $961.50M, a 47.70% increase from fiscal 2025.
- STERIS plc comprehensive income (loss), net of tax, attributable to parent for fiscal 2025 was $651.00M, a 75.80% increase from fiscal 2024.
- STERIS plc comprehensive income (loss), net of tax, attributable to parent for fiscal 2024 was $370.30M.
- STERIS plc comprehensive income (loss), net of tax, attributable to parent for fiscal 2023 was -$3.87M, a 104.06% decline from fiscal 2022.
| Period end | Comprehensive Income (Loss), Net of Tax, Attributable to Parent 3 month | Comprehensive Income (Loss), Net of Tax, Attributable to Parent 3 month as first filed | Comprehensive Income (Loss), Net of Tax, Attributable to Parent 6 month | Comprehensive Income (Loss), Net of Tax, Attributable to Parent 6 month as first filed | Comprehensive Income (Loss), Net of Tax, Attributable to Parent 9 month | Comprehensive Income (Loss), Net of Tax, Attributable to Parent 9 month as first filed | Comprehensive Income (Loss), Net of Tax, Attributable to Parent 12 month | Comprehensive Income (Loss), Net of Tax, Attributable to Parent 12 month as first filed |
|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | $186.00M 10-Q · filed 2026-08-07 | $335.80M derived: sum of 2 quarters · filed 2026-08-07 | $562.00M derived: sum of 3 quarters · filed 2026-08-07 | $748.30M derived: sum of 4 quarters · filed 2026-08-07 | ||||
| 2026-03-31 | $149.80M derived: 10-K 12 month − 10-Q 9 month · filed 2026-05-29 | $376.00M derived: sum of 2 quarters · filed 2026-05-29 | $562.30M derived: sum of 3 quarters · filed 2026-05-29 | $961.50M 10-K · filed 2026-05-29 | ||||
| 2025-12-31 | $226.20M 10-Q · filed 2026-02-06 | $412.50M derived: sum of 2 quarters · filed 2026-02-06 | $811.70M 10-Q · filed 2026-02-06 | $1.04B derived: sum of 4 quarters · filed 2026-08-07 | ||||
| 2025-09-30 | $186.30M 10-Q · filed 2025-11-06 | $585.40M 10-Q · filed 2025-11-06 | $813.10M derived: sum of 3 quarters · filed 2026-08-07 | $778.20M derived: sum of 4 quarters · filed 2026-08-07 | ||||
| 2025-06-30 | $399.20M 10-Q · filed 2026-08-07 | $626.80M derived: sum of 2 quarters · filed 2026-08-07 | $591.90M derived: sum of 3 quarters · filed 2026-08-07 | $899.20M derived: sum of 4 quarters · filed 2026-08-07 | ||||
| 2025-03-31 | $227.60M derived: 10-K 12 month − 10-Q 9 month · filed 2026-05-29 | $192.70M derived: sum of 2 quarters · filed 2026-05-29 | $500.00M derived: sum of 3 quarters · filed 2026-05-29 | $651.00M 10-K · filed 2026-05-29 | $650.96M 10-K · filed 2025-05-29 | |||
| 2024-12-31 | -$34.90M 10-Q · filed 2026-02-06 | -$34.88M 10-Q · filed 2025-02-07 | $272.40M derived: sum of 2 quarters · filed 2026-02-06 | $423.40M 10-Q · filed 2026-02-06 | $423.38M 10-Q · filed 2025-02-07 | $346.00M derived: sum of 4 quarters · filed 2026-05-29 | ||
| 2024-09-30 | $307.30M 10-Q · filed 2025-11-06 | $307.27M 10-Q · filed 2024-11-07 | $458.20M 10-Q · filed 2025-11-06 | $458.26M 10-Q · filed 2024-11-07 | $380.90M derived: sum of 3 quarters · filed 2026-05-29 | $655.75M derived: sum of 4 quarters · filed 2026-05-29 | ||
| 2024-06-30 | $151.00M 10-Q · filed 2025-08-07 | $150.99M 10-Q · filed 2024-08-08 | $73.60M derived: sum of 2 quarters · filed 2026-05-29 | $348.45M derived: sum of 3 quarters · filed 2026-05-29 | $387.89M derived: sum of 4 quarters · filed 2026-05-29 | |||
| 2024-03-31 | -$77.40M derived: 10-K 12 month − 10-Q 9 month · filed 2026-05-29 | $197.45M derived: sum of 2 quarters · filed 2026-05-29 | $236.90M derived: sum of 3 quarters · filed 2026-05-29 | $370.30M 10-K · filed 2026-05-29 | $370.29M 10-K · filed 2024-05-29 | |||
| 2023-12-31 | $274.85M 10-Q · filed 2025-02-07 | $314.29M derived: sum of 2 quarters · filed 2025-02-07 | $447.70M 10-Q · filed 2025-02-07 | $678.38M derived: sum of 4 quarters · filed 2025-05-29 | ||||
| 2023-09-30 | $39.44M 10-Q · filed 2024-11-07 | $172.85M 10-Q · filed 2024-11-07 | $403.53M derived: sum of 3 quarters · filed 2025-05-29 | $761.34M derived: sum of 4 quarters · filed 2025-05-29 | ||||
| 2023-06-30 | $133.41M 10-Q · filed 2024-08-08 | $364.08M derived: sum of 2 quarters · filed 2025-05-29 | $721.90M derived: sum of 3 quarters · filed 2025-05-29 | $196.84M derived: sum of 4 quarters · filed 2025-05-29 | ||||
| 2023-03-31 | $230.68M derived: 10-K 12 month − 10-Q 9 month · filed 2025-05-29 | $588.49M derived: sum of 2 quarters · filed 2025-05-29 | $63.43M derived: sum of 3 quarters · filed 2025-05-29 | -$3.87M 10-K · filed 2025-05-29 | ||||
| 2022-12-31 | $357.81M 10-Q · filed 2024-02-08 | -$167.25M derived: sum of 2 quarters · filed 2024-02-08 | -$234.55M 10-Q · filed 2024-02-08 | -$255.22M derived: sum of 4 quarters · filed 2024-05-29 | ||||
| 2022-09-30 | -$525.06M 10-Q · filed 2023-11-07 | -$592.36M 10-Q · filed 2023-11-07 | -$613.03M derived: sum of 3 quarters · filed 2024-05-29 | -$500.55M derived: sum of 4 quarters · filed 2024-05-29 | ||||
| 2022-06-30 | -$67.30M 10-Q · filed 2023-08-08 | -$87.97M derived: sum of 2 quarters · filed 2024-05-29 | $24.51M derived: sum of 3 quarters · filed 2024-05-29 | $25.40M derived: sum of 4 quarters · filed 2024-05-29 | ||||
| 2022-03-31 | -$20.67M derived: 10-K 12 month − 10-Q 9 month · filed 2024-05-29 | $91.81M derived: sum of 2 quarters · filed 2024-05-29 | $92.70M derived: sum of 3 quarters · filed 2024-05-29 | $95.32M 10-K · filed 2024-05-29 | ||||
| 2021-12-31 | $112.48M 10-Q · filed 2023-02-08 | $113.37M derived: sum of 2 quarters · filed 2023-02-08 | $115.99M 10-Q · filed 2023-02-08 | $144.58M derived: sum of 4 quarters · filed 2023-05-26 | ||||
| 2021-09-30 | $895.00K 10-Q · filed 2022-11-09 | $3.51M 10-Q · filed 2022-11-09 | $32.10M derived: sum of 3 quarters · filed 2023-05-26 | $274.83M derived: sum of 4 quarters · filed 2023-05-26 | ||||
| 2021-06-30 | $2.62M 10-Q · filed 2022-08-08 | $31.21M derived: sum of 2 quarters · filed 2023-05-26 | $273.93M derived: sum of 3 quarters · filed 2023-05-26 | $457.53M derived: sum of 4 quarters · filed 2023-05-26 | ||||
| 2021-03-31 | $28.59M derived: 10-K 12 month − 10-Q 9 month · filed 2023-05-26 | $271.31M derived: sum of 2 quarters · filed 2023-05-26 | $454.91M derived: sum of 3 quarters · filed 2023-05-26 | $571.62M 10-K · filed 2023-05-26 | ||||
| 2020-12-31 | $242.73M 10-Q · filed 2022-02-09 | $426.33M derived: sum of 2 quarters · filed 2022-02-09 | $543.03M 10-Q · filed 2022-02-09 | $541.63M 10-Q · filed 2021-02-09 | $579.86M derived: sum of 4 quarters · filed 2022-05-31 | |||
| 2020-09-30 | $183.60M 10-Q · filed 2021-11-08 | $300.31M 10-Q · filed 2021-11-08 | $298.90M 10-Q · filed 2020-11-06 | $337.13M derived: sum of 3 quarters · filed 2022-05-31 | $518.86M derived: sum of 4 quarters · filed 2022-05-31 | |||
| 2020-06-30 | $116.71M 10-Q · filed 2021-08-09 | $115.30M 10-Q · filed 2020-08-07 | $153.53M derived: sum of 2 quarters · filed 2022-05-31 | $335.26M derived: sum of 3 quarters · filed 2022-05-31 | $361.16M derived: sum of 4 quarters · filed 2022-05-31 | |||
| 2020-03-31 | $36.83M derived: 10-K 12 month − 10-Q 9 month · filed 2022-05-31 | $218.55M derived: sum of 2 quarters · filed 2022-05-31 | $244.45M derived: sum of 3 quarters · filed 2022-05-31 | $331.97M 10-K · filed 2022-05-31 | $331.92M 10-K · filed 2020-05-29 | |||
| 2019-12-31 | $181.72M 10-Q · filed 2021-02-09 | $207.62M derived: sum of 2 quarters · filed 2021-02-09 | $295.14M 10-Q · filed 2021-02-09 | $410.81M derived: sum of 4 quarters · filed 2021-05-28 | ||||
| 2019-09-30 | $25.90M 10-Q · filed 2020-11-06 | $113.42M 10-Q · filed 2020-11-06 | $229.08M derived: sum of 3 quarters · filed 2021-05-28 | $236.69M derived: sum of 4 quarters · filed 2021-05-28 | ||||
| 2019-06-30 | $87.52M 10-Q · filed 2020-08-07 | $203.19M derived: sum of 2 quarters · filed 2021-05-28 | $210.80M derived: sum of 3 quarters · filed 2021-05-28 | $282.57M derived: sum of 4 quarters · filed 2021-05-28 | ||||
| 2019-03-31 | $115.66M derived: 10-K 12 month − 10-Q 9 month · filed 2021-05-28 | $123.28M derived: sum of 2 quarters · filed 2021-05-28 | $195.05M derived: sum of 3 quarters · filed 2021-05-28 | $134.23M 10-K · filed 2021-05-28 | $134.56M 10-K · filed 2019-05-30 | |||
| 2018-12-31 | $7.61M 10-Q · filed 2020-02-10 | $79.39M derived: sum of 2 quarters · filed 2020-02-10 | $18.57M 10-Q · filed 2020-02-10 | |||||
| 2018-09-30 | $71.77M 10-Q · filed 2019-11-07 | $10.95M 10-Q · filed 2019-11-07 | ||||||
| 2018-06-30 | -$60.82M 10-Q · filed 2019-08-07 | |||||||
| 2018-03-31 | $543.30M 8-K · filed 2021-02-09 | |||||||
| 2017-03-31 | -$62.58M 10-K · filed 2019-05-30 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| ZIMMER BIOMET HOLDINGS, INC. (ZBH) | United States | $17.103B | 20.66 |
| ALIGN TECHNOLOGY INC (ALGN) | United States | $10.346B | 29.06 |
| MSA Safety Inc (MSA) | United States | $7.023B | 21.47 |
| ESTABLISHMENT LABS HOLDINGS INC. (ESTA) | $1.954B | -65.76 | |
| Cadre Holdings, Inc. (CDRE) | United States | $1.123B | 33.88 |
| Enovis CORP (ENOV) | United States | $1.053B | -1.18 |
| Anteris Technologies Global Corp. (AVR) | United States | $0.746B | |
| Sanara MedTech Inc. (SMTI) | United States | $0.323B | -6.81 |
| Inogen Inc (INGN) | United States | $0.139B | -7.00 |
| Conexeu Sciences Inc. (CNXU) | United States | $0.111B |